7-(4-Fluorophenoxy)-2,4-bis(trifluoromethyl)-1,8-naphthyridine

Catalog No. :
ACNVKM271
CAS No. :
477852-34-9
Molecular Formula :
C16H7F7N2O
Molecular Weight :
376.23

IUPAC Name:7-(4-fluorophenoxy)-2,4-bis(trifluoromethyl)-1,8-naphthyridine

7-(4-Fluorophenoxy)-2,4-bis(trifluoromethyl)-1,8-naphthyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-(4-Fluorophenoxy)-2,4-bis(trifluoromethyl)-1,8-naphthyridine
IUPAC Name7-(4-fluorophenoxy)-2,4-bis(trifluoromethyl)-1,8-naphthyridine
MDL No.MFCD00140186
Molecular FormulaC16H7F7N2O
Molecular Weight376.23
SMILESFC(C1=CC(C(F)(F)F)=NC2=NC(OC3=CC=C(F)C=C3)=CC=C12)(F)F
InChI KeyLROYSHLQXUBFSF-UHFFFAOYSA-N
Synonym7-(4-FLUOROPHENOXY)-2,4-BIS(TRIFLUOROMETHYL)[1,8]NAPHTHYRIDINE;5,7-BIS(TRIFLUOROMETHYL)[1,8]NAPHTHYRIDIN-2-YL 4-FLUOROPHENYL ETHER;1,8-Naphthyridine, 7-(4-fluorophenoxy)-2,4-bis(trifluoromethyl)-
CAS No.477852-34-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACNVKM271 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYCUH790 route compound structure diagram
    ACYCUH790371-41-5 In Stock
  4. Then
  5. ACNVKM271 route product structure diagram
    ACNVKM271477852-34-9
Inquiry

2. ACNVKM271 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYCUH790 route compound structure diagram
    ACYCUH790371-41-5 In Stock
  4. Then
  5. ACNVKM271 route product structure diagram
    ACNVKM271477852-34-9
Inquiry

Comments (0)